Diphenylether derivative as selective inhibitor of protein tyrosine phosphatase 1B (PTP1B) over T-cell protein tyrosine phosphatase (TCPTP) identified through virtual screening

M. V V V Sekhar Reddy, Chakshusmathi Ghadiyaram, Sunil Kumar Panigrahi, Subramanya Hosahalli, Lakshmi Narasu Mangamoori

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Even though protein tyrosine phosphatase has been identified as a validated therapeutic target over a decade for type II diabetes and obesity, developing a selective inhibitor to protein tyrosine phosphatase 1B (PTP1B) over other cellular PTPases has been a complicated task owing to the highly conserved and polar nature of the PTP1B catalytic site. Virtual screening study of in-house chemical depository resulted in the prioritization of few low molecular weight compounds as PTP1B inhibitors. The in-vitro pNPP assays were carried out on prioritized compounds in both PTP1B and T-cell protein tyrosine phosphatase (TCPTP). From this we identified four low molecular weight compounds as PTP1B inhibitors, of which the compound AU-2439 has shown 5 fold selectivity towards PTP1B over highly homologous TCPTP. In this short communication selectivity of AU-2439 is explained based on interaction with critical active site residues in both proteins using docking models.

Original languageEnglish (US)
Pages (from-to)1602-1606
Number of pages5
JournalMini-Reviews in Medicinal Chemistry
Volume13
Issue number11
StatePublished - 2013
Externally publishedYes

Fingerprint

Non-Receptor Type 2 Protein Tyrosine Phosphatase
Non-Receptor Type 1 Protein Tyrosine Phosphatase
Catalytic Domain
Molecular Weight
Protein Tyrosine Phosphatases
Type 2 Diabetes Mellitus
Obesity

Keywords

  • Obesity
  • p-Nitro phenyl phosphate
  • PTP1B
  • TCPTP
  • Type II diabetes

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Diphenylether derivative as selective inhibitor of protein tyrosine phosphatase 1B (PTP1B) over T-cell protein tyrosine phosphatase (TCPTP) identified through virtual screening. / Sekhar Reddy, M. V V V; Ghadiyaram, Chakshusmathi; Panigrahi, Sunil Kumar; Hosahalli, Subramanya; Mangamoori, Lakshmi Narasu.

In: Mini-Reviews in Medicinal Chemistry, Vol. 13, No. 11, 2013, p. 1602-1606.

Research output: Contribution to journalArticle

Sekhar Reddy, M. V V V ; Ghadiyaram, Chakshusmathi ; Panigrahi, Sunil Kumar ; Hosahalli, Subramanya ; Mangamoori, Lakshmi Narasu. / Diphenylether derivative as selective inhibitor of protein tyrosine phosphatase 1B (PTP1B) over T-cell protein tyrosine phosphatase (TCPTP) identified through virtual screening. In: Mini-Reviews in Medicinal Chemistry. 2013 ; Vol. 13, No. 11. pp. 1602-1606.
@article{94de7e540a05473eb7536cacd4c6fa61,
title = "Diphenylether derivative as selective inhibitor of protein tyrosine phosphatase 1B (PTP1B) over T-cell protein tyrosine phosphatase (TCPTP) identified through virtual screening",
abstract = "Even though protein tyrosine phosphatase has been identified as a validated therapeutic target over a decade for type II diabetes and obesity, developing a selective inhibitor to protein tyrosine phosphatase 1B (PTP1B) over other cellular PTPases has been a complicated task owing to the highly conserved and polar nature of the PTP1B catalytic site. Virtual screening study of in-house chemical depository resulted in the prioritization of few low molecular weight compounds as PTP1B inhibitors. The in-vitro pNPP assays were carried out on prioritized compounds in both PTP1B and T-cell protein tyrosine phosphatase (TCPTP). From this we identified four low molecular weight compounds as PTP1B inhibitors, of which the compound AU-2439 has shown 5 fold selectivity towards PTP1B over highly homologous TCPTP. In this short communication selectivity of AU-2439 is explained based on interaction with critical active site residues in both proteins using docking models.",
keywords = "Obesity, p-Nitro phenyl phosphate, PTP1B, TCPTP, Type II diabetes",
author = "{Sekhar Reddy}, {M. V V V} and Chakshusmathi Ghadiyaram and Panigrahi, {Sunil Kumar} and Subramanya Hosahalli and Mangamoori, {Lakshmi Narasu}",
year = "2013",
language = "English (US)",
volume = "13",
pages = "1602--1606",
journal = "Mini-Reviews in Medicinal Chemistry",
issn = "1389-5575",
publisher = "Bentham Science Publishers B.V.",
number = "11",

}

TY - JOUR

T1 - Diphenylether derivative as selective inhibitor of protein tyrosine phosphatase 1B (PTP1B) over T-cell protein tyrosine phosphatase (TCPTP) identified through virtual screening

AU - Sekhar Reddy, M. V V V

AU - Ghadiyaram, Chakshusmathi

AU - Panigrahi, Sunil Kumar

AU - Hosahalli, Subramanya

AU - Mangamoori, Lakshmi Narasu

PY - 2013

Y1 - 2013

N2 - Even though protein tyrosine phosphatase has been identified as a validated therapeutic target over a decade for type II diabetes and obesity, developing a selective inhibitor to protein tyrosine phosphatase 1B (PTP1B) over other cellular PTPases has been a complicated task owing to the highly conserved and polar nature of the PTP1B catalytic site. Virtual screening study of in-house chemical depository resulted in the prioritization of few low molecular weight compounds as PTP1B inhibitors. The in-vitro pNPP assays were carried out on prioritized compounds in both PTP1B and T-cell protein tyrosine phosphatase (TCPTP). From this we identified four low molecular weight compounds as PTP1B inhibitors, of which the compound AU-2439 has shown 5 fold selectivity towards PTP1B over highly homologous TCPTP. In this short communication selectivity of AU-2439 is explained based on interaction with critical active site residues in both proteins using docking models.

AB - Even though protein tyrosine phosphatase has been identified as a validated therapeutic target over a decade for type II diabetes and obesity, developing a selective inhibitor to protein tyrosine phosphatase 1B (PTP1B) over other cellular PTPases has been a complicated task owing to the highly conserved and polar nature of the PTP1B catalytic site. Virtual screening study of in-house chemical depository resulted in the prioritization of few low molecular weight compounds as PTP1B inhibitors. The in-vitro pNPP assays were carried out on prioritized compounds in both PTP1B and T-cell protein tyrosine phosphatase (TCPTP). From this we identified four low molecular weight compounds as PTP1B inhibitors, of which the compound AU-2439 has shown 5 fold selectivity towards PTP1B over highly homologous TCPTP. In this short communication selectivity of AU-2439 is explained based on interaction with critical active site residues in both proteins using docking models.

KW - Obesity

KW - p-Nitro phenyl phosphate

KW - PTP1B

KW - TCPTP

KW - Type II diabetes

UR - http://www.scopus.com/inward/record.url?scp=84888074702&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888074702&partnerID=8YFLogxK

M3 - Article

C2 - 24000798

AN - SCOPUS:84888074702

VL - 13

SP - 1602

EP - 1606

JO - Mini-Reviews in Medicinal Chemistry

JF - Mini-Reviews in Medicinal Chemistry

SN - 1389-5575

IS - 11

ER -